BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma

Approximately, 50% of human melanomas are driven by BRAF mutations, which produce tumors that are highly immunosuppressive and often resistant to vaccine therapy. We introduced lipid-coated calcium phosphate nanoparticles (LCP NPs) as a carrier to efficiently deliver a tumor-specific antigen, the BR...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Immunol Immunother
Asıl Yazarlar: Liu, Qi, Zhu, Hongda, Liu, Yun, Musetti, Sara, Huang, Leaf
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Berlin Heidelberg 2017
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5801101/
https://ncbi.nlm.nih.gov/pubmed/29094184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-017-2079-7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller